Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Liau, L. M., Ashkan, K., Brem, S., Campian, J. L., Trusheim, J. E., Iwamoto, F. M., Tran, D. D., Ansstas, G., Cobbs, C. S., Heth, J. A., Salacz, M. E., D’Andre, S., Aiken, R. D., Moshel, Y. A., Nam, J. Y., Pillainayagam, C. P., Wagner, S. A., Walter, K. A., Chaudhary, R., … Bosch, M. L. (2023). Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma. JAMA Oncology, 9(1), 112. https://doi.org/10.1001/jamaoncol.2022.5370
Authors:
Linda M. Liau
Keyoumars Ashkan
Steven Brem
Jian L. Campian
John Trusheim
Fabio Iwamoto
David Tran
George Ansstas
Charles Cobbs
Jason Heth
Michael Salacz
Stacy D. D’Andre
Robert Aiken
Yaron A. Moshel
Joo Yeon Nam
Clement Pillainayagam
Stephanie A. Wagner
Kevin A. Walter
Rubina Chaudhary
Samuel Goldlust
Ian Lee
Daniela A. Bota
Heinrich Elinzano
Jai Grewal
Kevin O. Lillehei
Tom Mikkelsen
Tobias Walbert
Steven R. Abram
Andrew Brenner
Matthew G. Ewend
Simon Khagi
Darren Lovick
Jana Portnow
Lyndon Kim
William G. Loudon
Nina Martinez
Reid C. Thompson
David Avigan
Karen Fink
Francois J. Geoffroy
Pierre Giglio
Oleg Gligich
Dietmar Krex
Scott Lindhorst
Jose Lutzky
Hans-Joerg Meisel
Minou Nadji-Ohl
Lhagva Sanchin
Andrew E. Sloan
Lynne P. Taylor
Julian K. Wu
Priya Kumthekar
Arnold B. Etame
Santosh Kesari
David Mathieu
David E. Piccioni
David S. Baskin
Michel Lacroix
Sven-Axel May
Pamela New
Timothy Pluard
Steven Toms
Victor Tse
Scott Peak
John L. Villano
James Battiste
Paul Mulholland
Michael Pearlman
Kevin Petrecca
Michael Schulder
Robert M. Prins
Alton L. Boynton
Marnix L. Bosch
Affiliated Authors:
Fabio Iwamoto
Subjects:
Glioblastoma (MeSH)
Gliomas (OpenAlex Topic)
Cancer Immunotherapy (OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1001/jamaoncol.2022.5370
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: